Using virtual reality to recover from a cerebro-vascular accident
May 19, 2011 By Cécilia Carron in Neuroscience
Its possible to regain mobility in your arms using Nano after a cerebro-vascular accident (CVA). Developed by MindMaze, an EPFL spin-off company, this device can be used every day at home.
Portable, accessible and easy to use, the Nano represents a small revolution in neuromuscular rehabilitation after a cerebro-vascular accident. This therapy, using equipment that fits into a small briefcase, works using virtual reality. It consists of a screen, a webcam, a pair of dark glasses, a helmet fitted with electrodes, and a glove: the patient puts on the equipment, presses ON and the session starts. This ease of use makes it suitable for daily practice at home. The first few weeks are known to be the most important for recovery. This is when many people give up, emphasizes Tej Tadi, founder of MindMaze, the start-up based at The Garage EPFLs breeding-ground for new companies which is developing the "Nano".
This video is not supported by your browser at this time.
Making progress using an avatarThe physiotherapy is based on a simple principle: observing the scene that is supposed to represent us is enough, gradually, to reactivate the damaged region of the brain. When the patient moves his active hand, he actually sees the 3D avatar of his disabled limb moving through his glasses. This activates a region of the cortex adjacent to the damaged area, which then slowly takes over.
The exercises are then carried out with the disabled limb: stretching the arm, picking up an object, or pointing at something.
Doctors can access real-time data
The electrodes fitted to the helmet provide constant data on the brains activity. Transmitted via the internet with a 3D-image of the brain, these enable the medical staff to see the changes in the patients brain directly, while remaining at the hospital, and to give him instructions. The patient can follow his progress through the display of this data in the form of a graphic.
The system is due to be marketed by the end of this year. Its currently in the preclinical trials stage at the Vaud cantons university hospital (CHUV). For now it would seem that mobility is also being recovered more rapidly than with the programs currently on offer.
Every year 10,000 people in Switzerland and 12 million worldwide are affected by a CVA. We began by suggesting a device designed to rehabilitate the arm, because this is the main handicap for 75% of patients who have undergone a CVA, emphasizes Tej Tadi, who developed this technology during his doctoral work at the EPFL Laboratory of Cognitive Neuroscience.
An EPFL spin-off company, the MindMaze start-up has already won several awards, including the Venture Leaders in 2010 and PERL (Prix Entreprendre Région Lausanne), the prize awarded by the Association of communes of the Lausanne region, in March last year. The companys founder plans to put the first device on sale in mid- 2012. The Swiss and German markets, where the company will begin operations, are valued at 55 million francs. An international launch is planned for three years from now.
Provided by Ecole Polytechnique Federale de Lausanne
-
Shopping simulator leads to better therapy
May 13, 2011 |
not rated yet |
0
-
Structural brain changes in people at risk for Alzheimer’s disease
Nov 17, 2010 |
not rated yet |
0
-
Whole child taken into account with new study
Feb 04, 2011 |
not rated yet |
0
-
Newborn ear deformities corrected without surgery
Jan 24, 2011 |
not rated yet |
0
-
Virtual reality in a Michigan Tech lab
Mar 07, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
New neuron formation could increase capacity for new learning, at the expense of old memories
New research presented today shows that formation of new neurons in the hippocampus - a brain region known for its importance in learning and remembering - could cause forgetting of old memories by causing a reorganization ...
Neuroscience
May 24, 2013 |
4 / 5 (4) |
0
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Neuroscience
May 24, 2013 |
4 / 5 (2) |
2
Japanese research organizations contribute to Human Brain Project
One of the major frontiers of modern science is a comprehensive understanding of the human brain and its functions to guide the development of new technologies in information and communication. In a major announcement for ...
Neuroscience
May 24, 2013 |
3.7 / 5 (3) |
0
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Neuroscience
May 23, 2013 |
4.9 / 5 (10) |
0
|
Brain uses internal 'average voice' prototype to identify who is talking
(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.
Neuroscience
May 23, 2013 |
3.7 / 5 (3) |
3
|
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.